Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV

BACKGROUND: High dosage of intravenous immunoglobulin (IVIG) has been observed as a possible activator of HIV gene expression in latently infected resting CD4(+ )T-cells, leading to a substantial decrease in both the reservoir and the residual plasma viremia when added to effective ART. IVIG treatme...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Mellberg, Tomas, Gonzalez, Veronica D, Lindkvist, Annica, Edén, Arvid, Sönnerborg, Anders, Sandberg, Johan K, Svennerholm, Bo, Gisslén, Magnus
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2011
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3136401/
https://ncbi.nlm.nih.gov/pubmed/21708049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-8-21
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg